张力腿平台涡激运动特性的试验研究

文章基于物理模型试验,对张力腿平台的涡激运动问题进行了探讨,研究了横向和顺流向涡激运动频率及响应特性。试验结果表明:在锁定区,涡激运动频率与平台在海流中的位置有关。当结构沿流向对称时,顺流向振荡频率是横向振荡频率的两倍;当结构沿流向不对称时,顺流向振荡频率与横向振荡频率相同。试验结果还表明,流向角是影响平台运动轨迹的关键因素,当流向角为0°和45°时,平台运动轨迹呈不规则"8"字形;15°和30°时,运动轨迹为"香蕉形"。     

恒磁场对人脐动脉血管平滑肌细胞胞浆游离钙离子浓度的影响

目的 研究恒磁场对培养的人脐动脉血管平滑肌细胞(VSMC)胞浆内游离钙离子浓度([Ca2 ]i)的影响,探讨恒磁场抑制VSMC增殖的作用机制.方法 离体培养人脐动脉VSMC,不同强度的恒磁场垂直作用于VSMC,应用激光共聚焦显微镜观察恒磁场对VSMC胞浆[Ca2 ]i的影响.结果 5 mT的恒磁场作用于VSMC后10-50 min[Ca2 ]i较对照组明显下降,20 min下降最明显;其平滑肌细胞的Ca2 荧光强度明显弱于对照组,至60 min接近对照组.结论 恒磁场对VSMC胞浆[Ca2 ]i有明显降低作用,可能是抑制VSMC细胞增殖的机制.为经皮冠状动脉成型术(PTCA)术后再狭窄的治疗提供了新的理论基础.     

EPO对早期糖尿病大鼠肾脏的保护作用

目的观察亚临床剂量EPO对糖尿病大鼠早期肾损伤的影响,并探讨其作用机制。方法将大鼠随机分为正常对照组(NC)、糖尿病组(DM)及糖尿病EPO干预的两个剂量亚组(DMTA和DMTB)。采用链脲佐菌素诱导1型糖尿病大鼠模型,腹腔注射EPO10周后,测定血糖、血压、血红蛋白、肾功能;光镜及电镜下观察肾组织形态学变化;免疫组化分析肾组织细胞凋亡相关蛋白Bcl-2/Bax及细胞因子VEGF的表达。结果实验剂量EPO干预后,大鼠肾功能及其形态学指标得到显著改善;Bcl-2/Bax比值及VEGF表达升高;均呈剂量依赖性。血糖、血压、血红蛋白值与对照组相比无明显变化。结论亚临床剂量EPO可延缓早期糖尿病肾病发展进程,可能与上调Bcl-2/Bax蛋白表达比值,抑制肾脏细胞凋亡有关;在本实验条件下,肾组织VEGF的表达上调未对糖尿病肾病造成不良影响。     

Construction of lentivirus vectors carrying alphastatin gene and its secretion expression in human umbilical vein endothelia cells

Objective To construct lentivirus vectors carrying alphastatin gene, test its secretion expression in human umbilical vein endothelia cells (HUVECs) and observe its effects on growth, migration and tube formation of HUVECs. Methods We constructed recombinant lentivirus vectors of NT4-alphastatin fusion gene containing neurotrophin-4 signal peptide, pro-region sequences and alphastatin, then transfected the recombinant lentivirus vectors into HUVECs to obtain secretory protein alphastatin and test its anti-angiogenic activities in vitro. Results Our data showed that recombinant self-inactivating lentivirus vectors of NT4-alphastatin were successfully constructed, and stable NT4-alphastatin transduced HUVECs were capable of sustainably secreting alphastatin which significantly suppressed HUVECs migration and differentiation but not VEGF-induced proliferation. Conclusion This report represents the first time on the use of lentivirus-based vectors to deliver alphastatin, the endogenous angiogenesis inhibitor, and reveals the potential utility of anti-angiogenic gene therapy with lentivirus vectors for treating cancer.     

Expression and role of Tie-2 in rectal carcinoma

Objective To investigate the expression of Tie-2 in rectal carcinoma and its relationship with invasion and metastasis in rectal carcinoma. Materials S-P immunohistochemical assay was used to detect the expression of Tie-2 in 40 cases of rectal carcinoma and 10 cases of normal rectal tissues. Results Tie-2 was mainly localized in the cytoplasm and nucleus of vascular endothelial cells in cancerous tissues and partly in the cytoplasm of some cancerous cells. The expression of Tie-2 in rectal carcinoma was significantly higher than that in normal rectal tissues (P<0.05); however, Tie-2 expression was not associated with differentiation, invasion depth and Dukes stage (P>0.05), but with lymphatic metastasis (P<0.05). Conclusion Tie-2 plays a key role in carcinogenesis and lymph node metastasis of rectal carcinoma.     

雷帕霉素对小鼠H_(22)肝癌细胞生长增殖的影响

目的 研究雷帕霉素(rapamycin, RPM)对H_(22)肝癌细胞生长增殖的影响.方法 体外培养小鼠H_(22)肝细胞癌株,分别与RPM、CsA、FK506和5-Fu共同孵育48 h,进行MTT实验.流式细胞仪测定各组H_(22)细胞的细胞周期变化,ELISA法测定各组上清液中VEGF含量.体内实验建立H_(22)肝细胞癌皮下移植瘤模型,同时完成C57BL/6→BALB/c小鼠异体皮肤移植模型.给予RPM、CsA、FK506和5-Fu灌胃,观察皮片存活情况.获取实验小鼠血清及肿瘤组织.计算各组肿瘤体积,通过CD34免疫组化染色测定各组肿瘤组织的微血管密度(MVD).结果 剂量为0.01、0.1、1 mg/L的RPM对对数生长的H_(22)肝细胞具有细胞毒性,抑制H_(22)小鼠肝癌细胞增殖,培养上清液中的VEGF浓度较对照组显著降低(P<0.05),细胞周期分析显示S期细胞数较其他免疫抑制剂组显著减少(P<0.05).体内实验显示给予1.5 mg/(kg·d)和4.5 mg/(kg·d)的RPM与5 mg/(kg·d) FK506、20 mg/(kg·d) CsA的皮片存活时间相等,而肿瘤体积显著减小(P<0.05).与对照组相比,实验剂量RPM显著降低了荷瘤小鼠血清中的VEGF含量(P<0.05),同时瘤组织内的MVD显著减少(P<0.05).结论 体外实验研究和动物实验证实,RPM具有抗免疫排斥和抗肿瘤增殖的特点,可能在肝移植治疗肝脏恶性肿瘤方面发挥优势.     

rAAV2/1-Acrp30对动脉粥样硬化的GK大鼠NF-κB及黏附分子的影响

目的 观察rAAV2/1-Acrp30对动脉粥样硬化GK大鼠模型血清可溶性细胞间黏附分子(sICAM-1)、可溶性血管内皮黏附分子(sVCAM-1)水平和NF-κB表达的影响,从血管炎症的角度探讨脂联素对糖尿病大血管病变的作用.方法 将造模成功的30只动脉粥样硬化的GK大鼠分为三个处理组:①模型1组,后肢肌肉注射盐水;②模型2组,后肢肌肉注射空病毒rAAV2/1;③治疗组,后肢肌肉注射 rAAV2/1-Acrp30.治疗8周后处死所有大鼠,比较三组之间血清sICAM-1,sVCAM-1及主动脉处NF-κBp65 mRNA的表达水平.结果 治疗组和模型1组、模型2组比较,血清sVCAM-1、sICAM-1显著降低(P<0.05).治疗组和模型1组、模型2组比较,主动脉NF-κBp65 mRNA表达显著下调(P<0.05).结论 rAAV2/1-Acrp30可通过抑制NF-κB的表达,减轻炎症反应而对糖尿病大血管病变产生保护作用.     

Glutamate enhances the expression of vascular endothelial growth factor in cultured SD rat astrocytes

Objective To study the effect of glutamate on the expression of vascular endothelial growth factor (VEGF) mRNA and protein in cultured rat astrocytes. Methods Cultured rat astrocytes were randomly divided into 6 groups: control group (C), glutamate group (G), QA group (Q), DCG-IV group (D), L-AP4 group (L) and glutanmte-FMCPG gronp (G+M). Cells were cultured under nomoxic condition (95% air, 5% CO2). RT-PCR and ELISA methods were used to detect the expression of VEGF mRNA and protein in cultured astrocytes, respectively. G+ M group was preincubated with lmM MCPG for 30 min prior to the stimulation with glutamate. There were 7 time points at 0,4,8,12,16,24 and 48 h in each group except G+M group. Results The expression of VEGF mRNA and protein did not differ significantly among D group, L group and C group. Different from that in C group, the expression of VEGF mRNA and protein could be enhanced both in a dose-dependent and time-dependent manner in G group and Q group. Meanwhile, the enhanced expression of VEGF mRNA and protein in G group was completely suppressed by MCPG after 24 h. Conclusion Glutamate can increase the expression of VEGF mRNA and protein in cultured astrocytes, which may be due to the activation of group I metabotropic glutamate receptors in astrocytes.     

血清可溶性血管内皮生长因子受体-1在AECOPD患者合并肺炎风险评估和预后判断中的价值

目的分析可溶性血管内皮生长因子受体-1(sFlt-1)在慢性阻塞性肺疾病急性加重期(AECOPD)是否合并社区获得性肺炎(CAP)患者中的差异,并评估其判断预后的潜力。方法对2016年1月至2017年10月就诊于浙江省立同德医院及温州市中心医院连续性符合条件的CAP患者(n=48)、CAP+AECOPD患者(n=20)或AECOPD(n=34)患者进行了前瞻性队列研究。通过常规自动化测试C-反应蛋白(CRP)、hs肌钙蛋白T、NTproBNP、降钙素原和血液计数,并采用电化学发光免疫法分析sFlt-1水平。结果不同诊断组患者的炎症指标、sFlt-1、血红蛋白、纤维蛋白原有明显差异(P<0.05)。CAP+AECOPD组的CRP、sFlt-1、降钙素原、hs肌钙蛋白T、NT-proBNP、纤维蛋白原较AECOPD组显著升高(P<0.05),而血红蛋白较AECOPD组显著下降(P<0.05)。CRP(r=0.504,P=0.005)、sFlt-1(r=0.384,P=0.009)和降钙素原(r=0.307,P=0.042)与住院时间呈显著正相关。与入院时相比,sFlt-1水平在出院后再入院的患者中表现更高[(27.91±5.82)ng/L vs.(16.26±4.33)ng/L,P=0.022],并且在30 d内死亡患者中sFlt-1水平[(30.46±5.74)ng/L]更高。sFlt-1水平高于19.451 ng/L区分AECOPD和CAP+AECOPD的阳性预测值为66%,阴性预测值为80%,灵敏度为66%,特异性为80%,ROC曲线下面积为0.78。结论血清sFlt-1水平能快速区分AECOPD患者是否合并CAP,而且可以初步预测住院时间和短期临床预后。     

骨保护素是高血压患者冠脉钙化的独立危险因素并与血管紧张素Ⅱ相关

目的评估高血压患者血浆骨保护素(osteoprotegerin, OPG)水平与冠脉钙化之间的关系,以及OPG与血管紧张素Ⅱ(angiotensinⅡ, AngⅡ)之间的相关性。方法研究入选了348例高血压患者,64排冠脉CT检查明确患者冠脉钙化情况,根据钙化评分将高血压患者分为冠脉钙化组与非冠脉钙化组,比较两组患者的临床与实验室指标,计算患者冠脉钙化危险因素的比值比(odds ratio, OR),以及患者血浆OPG与AngⅡ水平的相关系数。结果高血压伴冠脉钙化组患者OPG与AngⅡ水平均高于非冠脉钙化患者(P均<0.001)。多因素Logistics回归分析显示,OPG水平(OR 3.728;95%CI 1.314～7.714)与AngⅡ水平(OR 2.385;95%CI 1.281～4.836)均是冠脉钙化独立危险因素(P<0.001),并且OPG、AngⅡ水平与冠脉钙化的严重程度相关。在高血压伴冠脉钙化患者中,OPG水平与AngⅡ水平呈正相关(P<0.001,r=0.509);而在非冠脉钙化患者中,OPG水平与AngⅡ水平无关(P>0.05)。结论 OPG是高血压患者冠脉钙化的独立危险因素,并与冠脉钙化严重程度有关;在高血压伴冠脉钙化患者中,OPG与AngⅡ水平呈正相关。